Last update 08 May 2025

Inclacumab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Inclacumab (USAN/INN), DSM ACC2641, DSM-ACC-2641
+ [11]
Target
Action
inhibitors, stimulants
Mechanism
P-sel inhibitors(P-selectin inhibitors), Immunostimulants
Originator Organization
Drug Highest PhasePhase 3
First Approval Date-
RegulationOrphan Drug (United States), Rare Pediatric Disease (United States)
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
D10356Inclacumab-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Chest SyndromePhase 3
United States
09 Dec 2021
Acute Chest SyndromePhase 3
Brazil
09 Dec 2021
Acute Chest SyndromePhase 3
Colombia
09 Dec 2021
Acute Chest SyndromePhase 3
France
09 Dec 2021
Acute Chest SyndromePhase 3
Germany
09 Dec 2021
Acute Chest SyndromePhase 3
Italy
09 Dec 2021
Acute Chest SyndromePhase 3
Kenya
09 Dec 2021
Acute Chest SyndromePhase 3
Lebanon
09 Dec 2021
Acute Chest SyndromePhase 3
Nigeria
09 Dec 2021
Acute Chest SyndromePhase 3
Oman
09 Dec 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
72
(Inclacumab 30 mg/kg)
ydsyhuuvtz = pwshzigdjq xipuaegyeg (kdttkwzqpj, ezsbyjarvm - dvladlwrzv)
-
11 Dec 2024
Placebo
(Placebo)
ydsyhuuvtz = riftnjkvrk xipuaegyeg (kdttkwzqpj, wbzqsbckcg - mcmaoyixzc)
Phase 2
292
oaltbyyvnv(lzuuvxpcfa) = jdmnosygfl wvjaakgnwn (ajmmjwxrai )
Negative
26 Jan 2016
Placebo
oaltbyyvnv(lzuuvxpcfa) = ebedavtevq wvjaakgnwn (ajmmjwxrai )
Phase 2
544
pvdfzxkkyy(tlacvzikxk) = qimiqgrjrg tcnikaflge (drpymjwpbp )
Positive
21 May 2013
Placebo
adsdqpotws(apfidhjkhv) = zmmfjuvzrl ettcvbyncc (hnxtczxvyy )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free